Compare MWA & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MWA | APGE |
|---|---|---|
| Founded | 1857 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.7B |
| IPO Year | 2006 | 2023 |
| Metric | MWA | APGE |
|---|---|---|
| Price | $24.76 | $77.47 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | $29.00 | ★ $99.44 |
| AVG Volume (30 Days) | ★ 1.4M | 926.2K |
| Earning Date | 02-03-2026 | 11-10-2025 |
| Dividend Yield | ★ 1.13% | N/A |
| EPS Growth | ★ 64.86 | N/A |
| EPS | ★ 1.22 | N/A |
| Revenue | ★ $1,429,700,000.00 | N/A |
| Revenue This Year | $3.73 | N/A |
| Revenue Next Year | $3.71 | N/A |
| P/E Ratio | $20.34 | ★ N/A |
| Revenue Growth | ★ 8.75 | N/A |
| 52 Week Low | $21.35 | $26.20 |
| 52 Week High | $28.58 | $80.99 |
| Indicator | MWA | APGE |
|---|---|---|
| Relative Strength Index (RSI) | 54.12 | 67.49 |
| Support Level | $24.41 | $73.55 |
| Resistance Level | $24.96 | $80.44 |
| Average True Range (ATR) | 0.48 | 3.14 |
| MACD | 0.04 | -0.47 |
| Stochastic Oscillator | 62.18 | 72.26 |
Mueller Water Products Inc is a U.S.-based company that manufactures and sells products and services used in the transmission, distribution, and measurement of water. The company operates in two segments Water Flow Solutions and Water Management Solutions. The Water Flow Solutions segment, which derives maximum revenue for the company, includes products like iron gate valves, specialty valves, and service brass products. Water Management Solutions' portfolio includes fire hydrants, repair and installation, natural gas, metering, leak detection, and pressure management and control products and solutions. Geographically, the company derives a majority of its revenue from the United States and the rest from Canada and other international locations.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.